blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3701947

EP3701947 - IMMUNOMODULATION BY IAP INHIBITORS [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  07.10.2022
Database last updated on 20.09.2024
FormerRequest for examination was made
Status updated on  19.02.2021
FormerThe application has been published
Status updated on  31.07.2020
Most recent event   Tooltip27.04.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Novartis AG
Lichtstrasse 35
4056 Basel / CH
For all designated states
Dana-Farber Cancer Institute, Inc.
450 Brookline Avenue
Boston, MA 02215 / US
[2020/36]
Inventor(s)01 / ZAWEL, Leigh
55 Winter street
Arlington, MA Massachusetts 02474 / US
02 / DRANOFF, Glenn
28 Outlook Drive
Lexingtton, MA Massachusetts 02421 / US
03 / DOUGAN, Michael
1788 Beacon Street, Apt. 1A
Brookline, MA Massachusetts 02445 / US
04 / STRAUB, Christopher, S.
16 Heritage Lane
Stow, MA Massachusetts 01775 / US
05 / FIRESTONE, Brant, G.
Novartis Institutes for Biomedical Research Inc.
220 Massachusetts Avenue
Cambridge, MA Massachusetts 02139 / US
 [2020/36]
Representative(s)D Young & Co LLP
3 Noble Street
London EC2V 7BQ / GB
[N/P]
Former [2020/36]D Young & Co LLP
120 Holborn
London EC1N 2DY / GB
Application number, filing date20159523.814.05.2009
[2020/36]
Priority number, dateUS20085394708P16.05.2008         Original published format: US 5394708 P
[2020/36]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3701947
Date:02.09.2020
Language:EN
[2020/36]
Search report(s)(Supplementary) European search report - dispatched on:EP17.07.2020
ClassificationIPC:A61K31/437
[2020/36]
CPC:
A61K31/4439 (EP,US); A61K31/421 (EP,US); A61K31/427 (EP,US);
A61K31/506 (EP,US); A61K39/0011 (EP,US); A61K39/39 (EP,US);
A61P31/00 (EP); A61P31/04 (EP); A61P31/10 (EP);
A61P31/12 (EP); A61P33/00 (EP); A61P33/02 (EP);
A61P35/00 (EP); A61P35/02 (EP); A61P37/02 (EP);
A61P37/04 (EP); A61P37/06 (EP); A61P43/00 (EP);
A61K2039/55511 (EP,US); A61K2039/80 (US); C12N5/0634 (EP,US) (-)
C-Set:
A61K31/421, A61K2300/00 (US,EP);
A61K31/427, A61K2300/00 (US,EP);
A61K31/437, A61K2300/00 (EP,US);
A61K31/506, A61K2300/00 (US,EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2021/12]
Former [2020/36]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
Extension statesALNot yet paid
BANot yet paid
RSNot yet paid
TitleGerman:IMMUNMODULATION DURCH IAP-HEMMER[2020/36]
English:IMMUNOMODULATION BY IAP INHIBITORS[2020/36]
French:IMMUNOMODULATION PAR INHIBITEURS IAP[2020/36]
Examination procedure17.02.2021Examination requested  [2021/12]
17.02.2021Date on which the examining division has become responsible
06.10.2022Despatch of a communication from the examining division (Time limit: M04)
25.01.2023Reply to a communication from the examining division
Parent application(s)   TooltipEP09747530.5  / EP2296650
Fees paidRenewal fee
26.02.2020Renewal fee patent year 03
26.02.2020Renewal fee patent year 04
26.02.2020Renewal fee patent year 05
26.02.2020Renewal fee patent year 06
26.02.2020Renewal fee patent year 07
26.02.2020Renewal fee patent year 08
26.02.2020Renewal fee patent year 09
26.02.2020Renewal fee patent year 10
26.02.2020Renewal fee patent year 11
20.03.2020Renewal fee patent year 12
11.05.2021Renewal fee patent year 13
21.03.2022Renewal fee patent year 14
27.04.2023Renewal fee patent year 15
26.04.2024Renewal fee patent year 16
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO2005077969  (VERTEX PHARMA [US], et al);
 [A]US2005197403  (HARRAN PATRICK G [US], et al);
 [A]WO2005094818  (GENENTECH INC [US], et al);
 [XD]WO2005097791  (NOVARTIS AG [CH], et al);
 [A]WO2008014236  (TETRALOGIC PHARMACEUTICALS COR [US], et al);
 [XD]WO2008016893  (NOVARTIS AG [CH], et al);
 [X]WO2008045905  (NOVARTIS AG [CH], et al);
 [X]WO2008057172  (NOVARTIS AG [CH], et al);
 [XP]WO2008067280  (NOVARTIS AG [CH], et al);
 [XP]WO2008109057  (DANA FARBER CANCER INST INC [US], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.